Cite
HARVARD Citation
Sugimoto, M. et al. (2022). A randomized controlled trial evaluating the effect of low-dose chlormadinone in patients with low-risk prostate cancer: PROSAS study. Japanese journal of clinical oncology. pp. 187-196. [Online].